Saama

Saama Technologies, founded in 1997 by Suresh Katta, specializes in AI-driven clinical analytics for the life sciences industry. The company leverages artificial intelligence, machine learning, and advanced data analytics to enhance drug development, clinical trials, and commercialization processes. With a global presence in the United States, India, and the UK, Saama emphasizes innovation through its dedicated AI research lab and has a history of strategic acquisitions to strengthen its capabilities. Saama offers a range of SaaS-based solutions tailored for life sciences, including a Data Hub for faster data discovery, Smart Data Quality for automating data checks, and Patient Insights for analyzing patient data efficiently. Their tools optimize clinical trial operations and streamline content drafting with an AI-Powered Document Generator. Saama serves pharmaceutical and biotech companies, playing a vital role in clinical trials, including partnerships during the COVID-19 pandemic. The company continues to invest in research and development to expand its AI capabilities and maintain its leadership in clinical data analytics.